tailieunhanh - HIV Medicine - part 8

An toàn và hiệu quả của adefovir dipivoxil ở bệnh nhân đồng nhiễm với HIV-1 và lamivudine chống siêu vi viêm gan B: một nghiên cứu thí điểm mở nhãn. Lancet năm 2001, 358:718-723. Benitez Bermijo, et al. Giảm lọc cầu thận trong bệnh nhân HIV được điều trị với tenofovir. | 582 HIV and Renal Function 4. Benhamou Y Bochet M Thibault V et al. Safety and efficacy of adefovir dipivoxil in patients coinfected with HIV-1 and lamivudine-resistant hepatitis B virus an open-label pilot study. Lancet 2001 358 718-723. 5. Benitez Bermijo et al. Decreased glomerular filtration in HIV patients treated with tenofovir. Abstract 3th IAS 2005 Rio. 6. Blick G Greiger-Zanlungo P Garton T Hatton E Lopez RJ. Tenofovir may cause severe hypophosphatemia in HIV AIDS patients with prior adefovir-induced renal tubular acidosis. Abstract 718 10th CROI 2003 Boston. 7. Breton et al. Tubulopathy consecutive to Tenofovir-containing antiretroviral therapy in two patients infected with Human Immunodeficiency J Infect Dis 2004 36 527-528. 454. 8. Gallant et al. TDF Compared to Nucleoside Reverse Transcriptase Inhibitors NRTIs IAS 2005 Abstract . 9. Gallant JE Staszewski S Pozniak AL et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients a randomized trial. JAMA 2004 292 191-201. 10. Gallant J Parish M Keruly J Moore R. Decline in renal function associated with tenofovir DF compared with nucleoside reverse transcriptase inhibitor treatment. Abstract 820 12th CROI 2005 Boston. 11. Gallais H Lazzarin A Adam A et al. The Viread Expanded Access Program in Europe Australia summary of the safety and efficacy of tenofovir disoproxil fumarate in antiretroviral treatment experience patients. Abstract TuPeB4552 15th IAC 2004 Bangkok. 12. Callens St et al. Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including TNF. J Infection 2003 47 262-263. 13. Cheng A Wulfsohn M Cheng SS Toole JJ. 2 year long term safety profile of tenofovir DF TDF in treatment-experienced patients from randomized double-blind placebo-controlled clinical trials. Abstract 156 9th EACS 2003 Warsaw. 14. Chin-Beckford N Kaul S Jayaweera DT. Comorbidities